投資評等
最後更新日期：2024/11/15
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2012/10/3 | UBS | Neutral >> Buy | $35 >> $39 |
| 2011/2/7 | Auriga U.S.A | Hold >> Buy | $29 >> $30 |
| 2010/11/19 | Barclays Capital | Equal Weight >> Overweight | $39 >> $39 |
| 2010/11/1 | Rodman & Renshaw | Mkt Perform >> Mkt Outperform | 37 |
| 2010/1/4 | Robert W. Baird | Neutral >> Outperform | $32 >> $38 |
| 2009/11/5 | Piper Jaffray | Neutral >> Overweight | $31 >> $37 |
| 2009/5/8 | Lazard Capital Mkts | Hold Buy | 37 |
| 2006/6/26 | Kaufman Bros | Hold Buy | 20 |
| 2005/3/16 | RBC Capital Mkts | Sector Perform->Outperform | 14 |
| 2005/1/4 | Sun Trust Rbsn Humphrey | Reduce->Neutral | 13 |
| 2004/12/3 | RBC Capital Mkts | Underperform->Sector Perform | |
| 2004/11/8 | Lazard Freres | Sell->Buy | 14 |
| 2003/12/31 | Davenport & Company | Buy->Strong Buy | |
| 2003/10/22 | First Albany | Neutral -> Buy | 18 |
| 2003/10/13 | Davenport & Company | Neutral -> Buy | |
| 2003/3/19 | Adams Harkness | Buy -> Strong Buy | 14 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/10/28 | Barclays | Overweight >> Equal Weight | $30 >> $28 |
| 2014/8/11 | Northland Capital | Outperform >> Market Perform | |
| 2012/1/5 | UBS | Buy >> Neutral | $34 >> $34 |
| 2011/1/28 | Robert W. Baird | Outperform >> Neutral | $45 >> $28 |
| 2011/1/12 | Wedbush | Outperform >> Neutral | $35 >> $33 |
| 2010/11/11 | Auriga U.S.A | Buy >> Hold | $85 >> $29 |
| 2010/5/3 | Rodman & Renshaw | Mkt Outperform >> Mkt Perform | |
| 2009/7/30 | Lazard Capital Mkts | Buy >> Hold | |
| 2005/7/27 | RBC Capital Mkts | Outperform->Sector Perform | |
| 2004/12/3 | CE Unterberg Towbin | Buy->Market Perform | |
| 2004/7/2 | Lehman Brothers | Overweight->Equal-weight | $12 |
| 2004/6/30 | Lazard Freres | Hold->Sell | |
| 2004/6/30 | Adams Harkness | Buy->Mkt Perform | |
| 2004/6/30 | Merrill Lynch | Buy->Neutral | |
| 2004/3/30 | RBC Capital Mkts | Sector Perform->Underperform | $17 |
| 2004/2/4 | JP Morgan | Neutral->Underweight | |
| 2003/7/11 | Bear Stearns | Outperform -> Peer Perform | |
| 2003/6/6 | Adams Harkness | Strong Buy -> Mkt Perform | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2012/10/1 | WallachBeth | Hold | 37 |
| 2011/6/10 | Wunderlich | Hold | 35 |
| 2011/5/18 | Oppenheimer | Outperform | 40 |
| 2010/12/7 | Boenning & Scattergood | Outperform | 35 |
| 2010/1/8 | Rodman & Renshaw | Mkt Outperform | 35 |
| 2009/11/16 | Barrington Research | Outperform | 36 |
| 2009/9/28 | Auriga U.S.A | Buy | 40 |
| 2009/9/4 | Robert W. Baird | Neutral | 28 |
| 2009/7/13 | Leerink Swann | Outperform | |
| 2009/3/12 | Wedbush Morgan | Buy | 39 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2011/5/4 | Auriga U.S.A | Hold | $30 >> $30 |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2011/9/23 | Barclays Capital | Overweight | $39 >> $43 |
| 2010/11/17 | Wedbush | Outperform | $48 >> $35 |
| 2010/7/30 | Wedbush | Outperform | $51 >> $49 |
| 2010/6/24 | Auriga U.S.A | Buy | $46 >> $52 |
| 2010/4/30 | Wedbush | Outperform | $42 >> $50 |
| 2010/4/27 | Wedbush | Outperform | $36 >> $42 |
| 2010/3/31 | Wedbush | Outperform | $34 >> $36 |
| 2006/4/13 | Lazard Captial | Buy | |
| 2006/4/13 | Kaufman Bros | Hold | |
| 2005/11/8 | First Albany | Buy | 21 |